Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-70

First 70 Last

Share
Profile

Follow
Mangoman605

1,603 Posts.

167

01/08/24

21:13

Post #: 75034745
Share

Originally posted by TanamiRod: ↑

And for clarity @Denial, I mean I am not a believer that they have anything that goes close to cover the cost of the P3 (ie:A$90m).

We know they have been previously offered a lowball that they rejected, so I know to the letter of the law, Mr Rennie, can always say there is "real interest".
That is what he has done all along, strung people along, by being vague and misleading.

He alluded to "hoping" this deal would cover the costs of the P3 and I would love to see that, as it gives this molecule a greater chance of making it to market, but I believe he has nothing like $90m and you guys will be asked to put your hand in your pocket again, upon FDA go ahead.

If he had A$90m in hand, both parties would have announced the below:
"We are pleased to announce that X big pharma company, has has agreed to fund the costs (up to $90m) of the upcoming P3 trial and receive exclusive distribution rights etc etc, CONDITIONAL on PAR receiving the greenlight from the FDA......
The share price would then double immediately (50c) and an additional cap raise could be done to cushion the cash account.

Just ask yourselves, why wouldn't both parties agree to the above? What is the downside of doing it this way??
Everyone wins. No big pharma has to stump up any cash if all goes wrong and PAR get to show to the world that they have a real backer that has put pen to paper.

Anyway, I have said it all before, as many have said, you will know soon!

Expand

You sure do provide us with a lot of commonsense
Rod.

PAR Price at posting: 25.5¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

KAI

Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales

A Super PITch is key in the competition for capital

MND

Albemarle lithium downsize burns $200M hole in Monadelphous's pocket as latter's contracts terminated

CKA

Deal with Petrosea opens the door for Cokal's ramp-up plans in Indonesia

Second Christmas for 2024 coming to Kalgoorlie: Diggers & Dealers starts Monday

There are more pages in this discussion • 8 more messages in this thread...

First 70 Last

Add PAR (ASX) to my watchlist

(20min delay)
Last 25.5¢		Change 0.010(4.08%)		Mkt cap ! $89.19M

Open	High	Low	Value	Volume
24.5¢	26.0¢	24.5¢	$65.17K	254.0K

Buyers (Bids)

No.	Vol.	Price($)
3	64000	25.0¢

Sellers (Offers)

Price($)	Vol.	No.
26.0¢	14407	2

View Market Depth

No.	Vol.	Price($)
3	64000	0.250
11	164185	0.245
8	120900	0.240
5	137753	0.235
5	134782	0.230

Price($)	Vol.	No.
0.260	14407	2
0.265	49987	1
0.270	20000	2
0.275	6347	2
0.280	59607	2

Last trade - 16.10pm 01/08/2024 (20 minute delay)

PAR (ASX) Chart

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-70

Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales

A Super PITch is key in the competition for capital

Albemarle lithium downsize burns $200M hole in Monadelphous's pocket as latter's contracts terminated

Deal with Petrosea opens the door for Cokal's ramp-up plans in Indonesia

Second Christmas for 2024 coming to Kalgoorlie: Diggers & Dealers starts Monday

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-70

Top Stories

Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales

A Super PITch is key in the competition for capital

Albemarle lithium downsize burns $200M hole in Monadelphous's pocket as latter's contracts terminated

Deal with Petrosea opens the door for Cokal's ramp-up plans in Indonesia

Second Christmas for 2024 coming to Kalgoorlie: Diggers & Dealers starts Monday

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News